Author Question: There are fifty low-risk people in a town and fifty high-risk people. A low-risk person has an ... (Read 169 times)

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
There are fifty low-risk people in a town and fifty high-risk people. A low-risk person has an average of 1,000 in medical expenses each year and is willing to pay 1,200 for medical insurance (this person is risk averse).
 
  A high-risk person has an average of 2,000 in medical expenses each year and is willing to pay 2,400 for medical insurance. Insurance companies are unable to tell who is high-risk and who is low-risk. a. Show that an insurance company would lose money if it offered medical insurance at a price of 1,600 b. Show that if the insurance company offered medical insurance at a price of 2,200, low-risk people would not be insured. Calculate total surplus if the price is 2,200 c. Now suppose the government in this town passes a law that requires everyone to purchase medical insurance and sets the price of insurance at 1,600 . Calculate total surplus under this law. d. The 2010 Patient Protection and Affordable Care Act (commonly called the Affordable Care Act, or Obamacare) includes an individual mandate that requires everyone to have health insurance. Does this question suggest that there is an efficiency argument in favor of the individual mandate? Defend your answer carefully.

Question 2

Torrie is thinking of starting up a small business selling hand-painted wine glasses. She is considering setting up her business as a sole proprietorship. What is one advantage to Torrie of setting up her business as a sole proprietorship?
 
  A) As a sole proprietor, Torrie would have the ability to share risk with shareholders.
  B) As a sole proprietor, Torrie would face limited liability.
  C) As a sole proprietor, Torrie would have both ownership and control over the business.
  D) All of the above would be advantages of setting up her business as a sole proprietorship.


kilada

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

a. Low risk people would be unwilling to buy insurance if the price is above 1,200 and so only high-risk people would be insured. The insurance company would have  on average  claims of 2,000 for each of its customers, which is more than the 1,600 price.
b. Low-risk people would be unwilling to buy insurance at a price of 2,200, but high-risk people would. Total willingness to pay will be 50 x 2,400 = 120,000, total producer cost will be 50 x 2,000 = 100,000 and so total surplus will be 120,000 - 100,000 = 20,000
c. Total willingness to pay will be (50 x 1,200) + (50 x 2,400) = 180,000, total producer cost will be (50 x 1,000) + (50 x 2,000) = 150,000 and so total surplus will be 180,000 - 150,000 = 30,000
d. We have shown that total surplus is higher if everyone is required to purchase health insurance (part c) than if people can decide for themselves whether or not buy insurance (parts a and b). Given asymmetric information in the health insurance market, government intervention can be justified on efficiency grounds.

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

According to the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of food allergy. Food allergies affect between 4 and 6% of children, and 4% of adults, according to the CDC. The most common food allergies include shellfish, peanuts, walnuts, fish, eggs, milk, and soy.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

The longest a person has survived after a heart transplant is 24 years.

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library